New Antibiotic-Producing Streptomycetes, Selected by Antibiotic Resistance as a Marker II. Features of a New Antibiotic-Producing Clone Obtained After Fusion Treatment

20Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A new antibiotic-producing Streptomyces strain SK2-52 obtained by a protoplast fusion treatment between Streptomyces griseus NP1-1 and S. tenjimariensis NM16 showed taxonomical features identical with those of S. griseus. The strain was resistant to wider range of aminoglycoside antibiotics than the parental strains. This multiple resistance corresponded to the activities of streptomycin kinase and acetyltransferase which were probably derived from S. griseus NP1-1. Clones with fast-growth and reduced antibiotic productivity frequently segregated from strain SK2-52, while their antibiotic resistance was stable. The results suggest that the fusion treatment caused a genetic change in S. griseus which enhanced the expression of genes for unique multiple resistance to aminoglycoside antibiotics and also induced new antibiotic production. © 1985, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Hotta, K., Yamashita, F., Okami, Y., & Umezawa, H. (1985). New Antibiotic-Producing Streptomycetes, Selected by Antibiotic Resistance as a Marker II. Features of a New Antibiotic-Producing Clone Obtained After Fusion Treatment. The Journal of Antibiotics, 38(1), 64–69. https://doi.org/10.7164/antibiotics.38.64

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free